These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15317557)

  • 1. Cutaneous reactions to interferon and ribavirin.
    Chamberlain AJ; Poon E
    Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.
    Sookoian S; Neglia V; Castaño G; Frider B; Kien MC; Chohuela E
    Arch Dermatol; 1999 Aug; 135(8):1000-1. PubMed ID: 10456365
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
    Castellanos González M; Pérez Carreras M; Muñoz Gómez R; Castellano Tortajada G
    Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
    [No Abstract]   [Full Text] [Related]  

  • 5. Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment.
    Vázquez-López F; Manjón-Haces JA; Pérez-Alvarez R; Pérez-Oliva N
    Br J Dermatol; 2004 May; 150(5):1046-7; author reply 1047. PubMed ID: 15149535
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Moore MM; Elpern DJ; Carter DJ
    Arch Dermatol; 2004 Feb; 140(2):215-7. PubMed ID: 14967798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
    Hashimoto Y; Kanto H; Itoh M
    J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
    Conde-Taboada A; de la Torre C; Feal C; Mayo E; Gonzalez-Sixto B; Cruces MJ
    Br J Dermatol; 2005 Nov; 153(5):1070-2. PubMed ID: 16225630
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    Shafa S; Borum ML; Igiehon E
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
    [No Abstract]   [Full Text] [Related]  

  • 10. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
    Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
    [No Abstract]   [Full Text] [Related]  

  • 11.  Pegylated interferon, but not conventional interferon therapy induced severe skin lesions.
    Li Z; Ji F; Zheng Y; An J; Peng Z
    Ann Hepatol; 2012; 11(4):570-1. PubMed ID: 22700642
    [No Abstract]   [Full Text] [Related]  

  • 12. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
    Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin.
    Patrk I; Morović M; Markulin A; Patrk J
    Dermatology; 2014; 228(1):42-6. PubMed ID: 24434490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection.
    Girard C; Bessis D; Blatìre V; Guilhou JJ; Guillot B
    Br J Dermatol; 2005 Jan; 152(1):182-3. PubMed ID: 15656829
    [No Abstract]   [Full Text] [Related]  

  • 15. How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients.
    Kasahara A
    J Gastroenterol; 2004 Nov; 39(11):1125-6. PubMed ID: 15580413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lichenoid eruption in a patient with chronic hepatitis C virus infection treated with interferon and ribavirin].
    Guillermo N; Hernández Santana J; Borrego L; Jorge M
    Gastroenterol Hepatol; 2009 Feb; 32(2):130-1. PubMed ID: 19231693
    [No Abstract]   [Full Text] [Related]  

  • 17. Leucopenia is a side effect of combination therapy for hepatitis C infection.
    Russo F; Bacosi M; Miglioresi L; Ricci GL
    Am J Gastroenterol; 2000 Apr; 95(4):1100-1. PubMed ID: 10763981
    [No Abstract]   [Full Text] [Related]  

  • 18. The uncertain natural history of thyrotoxic patients treated with combination interferon alfa-2beta and ribavirin.
    Tran HA
    Arch Intern Med; 2005 May; 165(9):1072; author reply 1072-3. PubMed ID: 15883255
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases.
    Lübbe J; Kerl K; Negro F; Saurat JH
    Br J Dermatol; 2005 Nov; 153(5):1088-90. PubMed ID: 16225644
    [No Abstract]   [Full Text] [Related]  

  • 20. Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin.
    Kerl K; Negro F; Lübbe J
    Br J Dermatol; 2003 Sep; 149(3):656. PubMed ID: 14511009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.